Furthermore, inhibiting spinal TG2 by cystamine reduces SOD1 oligomers, microglial activation and delayed progression in the G93A SOD1 mouse model of ALS (41). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.